{
    "title": "Drug Czar Responsibility and Accountability Act of 1998",
    "content": "SECTION 1. SHORT TITLE; AMENDMENT REFERENCES.\n\n    (a) Short Title.--This Act may be cited as the ``Drug Czar \nResponsibility and Accountability Act of 1998''.\n    (b) Amendment References.--Except as otherwise expressly provided, \nwhenever in this Act an amendment or repeal is expressed in terms of an \namendment to, or repeal of, a section or other provision, the reference \nshall be considered to be made to a section or other provision of the \nNational Narcotics Leadership Act of 1988 (21 U.S.C. 1501 et seq.).\n\nSEC. 2. FINDINGS.\n\n    Congress makes the following findings:\n            (1) Overall drug use among children aged 12 to 17 in 1992 \n        was 5.3 percent. In 1996, it was 9 percent, an increase of 70 \n        percent.\n            (2) Use of any illicit drug among 8th graders in 1992 was \n        12.9 percent. In 1997, it was 22.1 percent, an increase of 71 \n        percent.\n            (3) Use of any illicit drug among 10th graders in 1992 was \n        20.4 percent. In 1997, it was 38.5 percent, an increase of 91 \n        percent.\n            (4) Use of any illicit drug among 12th graders in 1992 was \n        27.1 percent. In 1997, it was 42.4 percent, an increase of 56 \n        percent.\n            (5) Use of marijuana among 8th graders in 1992 was 3.7 \n        percent. In 1997, it was 10.2 percent, an increase of 176 \n        percent.\n            (6) Use of marijuana among children aged 12 to 17 in 1992 \n        was 3.4 percent. In 1996, it was 7.1 percent, an increase of \n        109 percent.\n            (7) Use of cocaine among children aged 12 to 17 in 1992 was \n        0.3 percent. In 1996, it was 0.6 percent, an increase of 100 \n        percent.\n            (8) Marijuana-related medical emergencies in 1992 totaled \n        23,997. In 1996, there were 50,037 such emergencies, an \n        increase of 108 percent.\n            (9) Cocaine-related medical emergencies in 1992 totaled \n        119,843. In 1996, there were 144,180 such emergencies, an \n        increase of 20 percent.\n            (10) Heroin-related medical emergencies in 1992 totaled \n        48,003. In 1996, there were 70,463 such emergencies, an \n        increase of 47 percent.\n\nSEC. 3. EXPANSION OF RESPONSIBILITIES OF DIRECTOR.\n\n    (a) Expansion of Responsibilities.--Section 1003(b) (21 U.S.C. \n1502(b)) is amended--\n            (1) by striking paragraph (1) and inserting the following:\n            ``(1) establish Federal policies, objectives, goals, \n        priorities, and performance measures (including specific annual \n        agency targets expressed in terms of precise percentages) for \n        the National Drug Control Program and for each National Drug \n        Control Program agency, which shall include targets for \n        reducing the levels of overall unlawful drug use, adolescent \n        unlawful drug use, and drug-related emergency room incidents to \n        January 19, 1993 levels;'';\n            (2) by striking paragraph (3) and inserting the following:\n            ``(3) coordinate, oversee, and evaluate the effectiveness \n        of the implementation of the policies, objectives, goals, \n        performance measures, and priorities established under \n        paragraph (1) and the fulfillment of the responsibilities of \n        the National Drug Control Program agencies under the National \n        Drug Control Strategy;'';\n            (3) in paragraph (5), by inserting ``and nongovernmental \n        entities involved in demand reduction'' after ``governments'';\n            (4) in paragraph (7), by striking ``and'' at the end;\n            (5) in paragraph (8), by striking the period at the end and \n        inserting a semicolon; and\n            (6) by adding at the end the following:\n            ``(9) require each National Drug Control Program agency to \n        submit to the Director on a semi-annual basis (beginning with \n        the first 6 months of 1999) an evaluation of progress by the \n        agency with respect to drug control program goals using \nthe performance measures referred to in paragraph (1), including \nprogress with respect to--\n                    ``(A) success in reducing domestic and foreign \n                sources of illegal drugs;\n                    ``(B) success in protecting the borders of the \n                United States (and in particular the Southwestern \n                border of the United States) from penetration by \n                illegal narcotics;\n                    ``(C) success in reducing violent crime associated \n                with drug use in the United States;\n                    ``(D) success in reducing the negative health and \n                social consequences of drug use in the United States; \n                and\n                    ``(E) implementation of drug treatment and \n                prevention programs in the United States and \n                improvements in the adequacy and effectiveness of such \n                programs;\n            ``(10) submit to Congress on a semiannual basis, not later \n        than 60 days after the date of the last day of the applicable \n        6-month period, a summary of--\n                    ``(A) each evaluation received by the Director \n                under paragraph (9); and\n                    ``(B) the progress of each National Drug Control \n                Program agency toward the drug control program goals of \n                the agency using the performance measures described in \n                paragraph (1);\n            ``(11) require the National Drug Control Program agencies \n        to submit to the Director not later than February 1 of each \n        year a detailed accounting of all funds expended by the \n        agencies for National Drug Control Program activities during \n        the previous fiscal year, and require such accounting to be \n        authenticated by the Inspector General for each agency prior to \n        submission to the Director;\n            ``(12) submit to Congress not later than April 1 of each \n        year the information submitted to the Director under paragraph \n        (11);\n            ``(13) submit to Congress not later than August 1 of each \n        year a report including--\n                    ``(A) the budget guidance provided by the Director \n                to each National Drug Control Program agency for the \n                fiscal year in which the report is submitted and for \n                the other fiscal years within the applicable 5-year \n                budget plan relating to such fiscal year; and\n                    ``(B) a summary of the request of each National \n                Drug Control Program agency to the Director under this \n                Act (prior to review of the request by the Office of \n                Management and Budget) for the resources required to \n                achieve the targets of the agency under this Act;\n            ``(14) act as a representative of the President before \n        Congress on all aspects of the National Drug Control Program;\n            ``(15) act as the primary spokesperson of the President on \n        drug issues;\n            ``(16) make recommendations to National Drug Control \n        Program agency heads with respect to implementation of Federal \n        counter-drug programs;\n            ``(17) take such actions as necessary to oppose any attempt \n        to legalize the use of a substance (in any form) that--\n                    ``(A) is listed in schedule I of section 202 of the \n                Controlled Substances Act (21 U.S.C. 812); and\n                    ``(B) has not been approved for use for medical \n                purposes by the Food and Drug Administration; and\n            ``(18) ensure that drug prevention and drug treatment \n        research and information is effectively disseminated by \n        National Drug Control Program agencies to State and local \n        governments and nongovernmental entities involved in demand \n        reduction by--\n                    ``(A) encouraging formal consultation between any \n                such agency that conducts or sponsors research, and any \n                such agency that disseminates information in developing \n                research and information product development agendas;\n                    ``(B) encouraging such agencies (as appropriate) to \n                develop and implement dissemination plans that \n                specifically target State and local governments and \n                nongovernmental entities involved in demand reduction; \n                and\n                    ``(C) developing a single interagency clearinghouse \n                for the dissemination of research and information by \n                such agencies to State and local governments and \n                nongovernmental agencies involved in demand \n                reduction.''.\n    (b) Survey of Drug Use.--\n            (1) In general.--The University of Michigan shall not be \n        prohibited under any law from conducting the survey of drug use \n        among young people in the United States known as the Monitoring \n        the Future Survey.\n            (2) Other surveys.--The National Parents' Resource \n        Institute for Drug Education in Atlanta, Georgia, shall not be \n        prohibited under any law from conducting the survey of drug use \n        among young people in the United States known as the National \n        PRIDE Survey.\n\nSEC. 4. EXPANSION OF POWERS OF DIRECTOR.\n\n    Section 1003(d) (21 U.S.C. 1502(d)) is amended--\n            (1) in paragraph (9), by striking the period and inserting \n        a semicolon; and\n            (2) by adding at the end the following:\n            ``(10) require the heads of National Drug Control Program \n        agencies to provide the Director with statistics, studies, \n        reports, and any other information regarding Federal control of \n        drug abuse;\n            ``(11) require the heads of National Drug Control Program \n        agencies to provide the Director with information regarding any \n        position (before an individual is nominated for such position) \n        that--\n                    ``(A) relates to the National Drug Control Program;\n                    ``(B) is at or above the level of Deputy Assistant \n                Secretary; and\n                    ``(C) involves responsibility for Federal \n                counternarcotics or antidrug programs; and\n            ``(12) make recommendations to the National Drug \n        Intelligence Center on the specific projects that the Director \n        determines will enhance the effectiveness of implementation of \n        the National Drug Control Strategy.''.\n\nSEC. 5. SUBMISSION OF NATIONAL DRUG CONTROL STRATEGY.\n\n    (a) In General.--Section 1005(a) (21 U.S.C. 1504(a)) is amended--\n            (1) in paragraph (2)--\n                    (A) by striking subparagraph (A) and inserting the \n                following:\n            ``(A) include comprehensive, research-based, specific, \n        long-range goals and performance measures (including specific \n        annual targets expressed in terms of precise percentages) for \n        reducing drug abuse and the consequences of drug abuse in the \n        United States;'';\n                    (B) in subparagraph (C), by striking ``and'' at the \n                end;\n                    (C) by striking subparagraph (D);\n                    (D) by adding at the end the following:\n            ``(D) include 4-year projections for National Drug Control \n        Program priorities (including budget priorities); and\n            ``(E) review international, Federal, State, local, and \n        private sector drug control activities to ensure that the \n        United States pursues well-coordinated and effective drug \n        control at all levels of government.'';\n            (2) in paragraph (3)(A), by striking clauses (iv) and (v) \n        and inserting the following:\n            ``(iv) private citizens and organizations with experience \n        and expertise in demand reduction;\n            ``(v) private citizens and organizations with experience \n        and expertise in supply reduction; and\n            ``(vi) appropriate representatives of foreign \n        governments.'';\n            (3) in paragraph (4)--\n                    (A) in subparagraph (B), by striking clauses (i) \n                through (vi) and inserting the following:\n                    ``(i) the quantities of cocaine, heroin, marijuana, \n                methamphetamine, ecstasy, and rohypnol available for \n                consumption in the United States;\n                    ``(ii) the amount of cocaine, heroin, marijuana, \n                ecstasy, rohypnol, methamphetamine, and precursor \n                chemicals entering the United States;\n                    ``(iii) the number of hectares of marijuana, poppy, \n                and coca cultivated and destroyed domestically and in \n                other countries;\n                    ``(iv) the number of metric tons of marijuana, \n                cocaine, heroin, and methamphetamine seized;\n                    ``(v) the number of cocaine and methamphetamine \n                processing labs destroyed domestically and in other \n                countries;\n                    ``(vi) changes in the price and purity of heroin \n                and cocaine, changes in price of methamphetamine, and \n                changes in tetrahydrocannabinol level of marijuana;'';\n                    (B) in subparagraph (C), by striking ``and'' at the \n                end;\n                    (C) in subparagraph (D), by striking the period at \n                the end and inserting ``; and''; and\n                    (D) by adding at the end the following:\n            ``(E) assessment of the cultivation of illegal drugs in the \n        United States.''; and\n            (4) in paragraph (5)--\n                    (A) in the matter preceding subparagraph (A), by \n                striking ``February 1, 1995'' and inserting ``February \n                1, 1999'';\n                    (B) in the matter preceding subparagraph (A), by \n                striking ``second'';\n                    (C) in subparagraph (C), by striking ``and'' at the \n                end;\n                    (D) in subparagraph (D), by striking the period at \n                the end and inserting ``; and''; and\n                    (E) by adding at the end the following:\n            ``(E) a description of the National Drug Control Program \n        performance measures described in subsection (a)(2)(A).''.\n    (b) Goals and Performance Measures for National Drug Control \nStrategy.--Section 1005(b) (21 U.S.C. 1504(b)) is amended--\n            (1) in the heading, by striking ``, Objectives, and \n        Priorities'' and inserting ``and Performance Measures'';\n            (2) in the matter after the heading, by inserting ``(1)'' \n        before ``Each National Drug Control Strategy'';\n            (3) by redesignating paragraphs (1) through (6) as \n        subparagraphs (A) through (F), respectively;\n            (4) in subparagraph (A) (as redesignated by paragraph (3)), \n        by striking ``and priorities'' and inserting ``and performance \n        measures'';\n            (5) in subparagraph (C) (as redesignated by paragraph (3)), \n        by striking ``3-year projections'' and inserting ``4-year \n        projections''; and\n            (6) by adding at the end the following:\n    ``(2) In establishing the performance measures required by this \nsubsection, the Director shall--\n            ``(A) establish performance measures and targets expressed \n        in terms of precise percentages for each National Drug Control \n        Strategy goal and objective;\n            ``(B) revise such performance measures and targets as \n        necessary, and reflect such performance measures and targets in \n        the National Drug Control Program budget submitted to Congress;\n            ``(C) consult with affected National Drug Control Program \n        agencies;\n            ``(D) identify programs and activities of National Drug \n        Control Program agencies that support the goals of the National \n        Drug Control Strategy;\n            ``(E) evaluate in detail the implementation by each \n        National Drug Control Program agency of program activities \n        supporting the National Drug Control Strategy;\n            ``(F) monitor consistency between the drug-related goals of \n        the National Drug Control Program agencies and ensure that drug \n        control agency goals and budgets fully support, and are fully \n        consistent with, the National Drug Control Strategy;\n            ``(G) coordinate the development and implementation of \n        national drug control data collection and reporting systems to \n        support Federal policy formulation and performance measurement;\n            ``(H) ensure that no Federal drug control funds are \n        expended for any study or contract relating to the legalization \n        (for a medical use or any other use) of a substance listed in \n        schedule I of section 202 of the Controlled Substances Act (21 \n        U.S.C. 812); and\n            ``(I) ensure that no Federal funds appropriated for the \n        High Intensity Drug Trafficking Program are expended for the \n        expansion of drug treatment programs.''.\n\nSEC. 6. REPORT ON DESIGNATION OF HIGH INTENSITY DRUG TRAFFICKING AREAS.\n\n    Section 1005(c)(3) (21 U.S.C. 1504(c)(3)) is amended to read as \nfollows:\n    ``(3) Annual report.--Not later than March 1 of each year, the \nDirector shall submit to Congress a report--\n            ``(A) on the effectiveness of, and need for, the \n        designation of areas under this subsection as high intensity \n        drug trafficking areas; and\n            ``(B) that includes any recommendations of the Director for \n        legislative action with respect to such designation.''.\n\nSEC. 7. EXTENSION OF AUTHORIZATION OF APPROPRIATIONS.\n\n    Section 1011 (21 U.S.C. 1508) is amended by striking ``8 succeeding \nfiscal years'' and inserting ``10 succeeding fiscal years''.\n\nSEC. 8. REPORT REQUIRED.\n\n    Not later than November 1, 1998, the Director of the Office of \nNational Drug Control Policy shall submit to Congress a report \nincluding--\n            (1) proposed goals, targets, performance measures (as \n        described in section 1003(b)(1) of the National Narcotics \n        Leadership Act of 1988 (21 U.S.C. 1502(b)(1))), and specific \n        initiatives with respect to the National Drug Control Program, \n        including the High Intensity Drug Trafficking Area Program; and\n            (2) proposals to coordinate the efforts of all National \n        Drug Control Program agencies.\n\nSEC. 9. CONSISTENCY WITH NATIONAL SECURITY ACT OF 1947.\n\n    Section 1004 (21 U.S.C. 1503) is amended--\n            (1) in subsection (a)--\n                    (A) by striking ``(1)'';\n                    (B) by striking ``(2)(A)'' and inserting ``(b) \n                Consistency With National Security Act of 1947.--(1)'';\n                    (C) by striking ``(B)'' and inserting ``(2)''; and\n                    (D) by striking ``subparagraph (A)'' and inserting \n                ``paragraph (1)''; and\n            (2) by redesignating subsections (b) and (c) as subsections \n        (c) and (d), respectively."
}